PDCD1 and malignant pleural mesothelioma: Statins were also related to better ORR, longer PFS and OS, in a retrospective cohort of patients with thoracic cancer (82 with malignant pleural mesothelioma and 179 with NSCLC) treated with PD-1 inhibitors [96].